HM2
HM2
规格:
货期:
编号:TS211990
品牌:Testobio
| 产品名称： | HM2 |
|---|---|
| 商品货号： | TS211990 |
| Organism： | human (T cell); human (T cell leukemia) |
| Cell Type： | hybridoma: helper T lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 Cells Contain RETROVIRUS
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Leukemia,hepatitis |
| Applications： | The cells produce a SSF that specifically inhibits T cell dependent immune functions. NOTE: this line should be handled with care since one of the fusion partners was derived from a patient with AIDS. Hepatitis B virus precautions are recommended by the depositor. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | T cells from a patient with acquired immunodeficiency syndrome (AIDS) were fused with K37.3.2 human T cell leukemia cells. NOTE: this line should be handled with care since one of the fusion partners was derived from a patient with AIDS. |
| Clinical Data： | T cells from a patient with acquired immunodeficiency syndrome (AIDS) were fused with K37.3.2 human T cell leukemia cells. NOTE: this line should be handled with care since one of the fusion partners was derived from a patient with AIDS. |
| Antigen Expression： | Leu 3a; CD4 |
| Genes Expressed： | soluble suppression factor (SSF),Leu 3a; CD4 |
| Cellular Products： | soluble suppression factor (SSF) |
| Comments： | T cells from a patient with acquired immunodeficiency syndrome (AIDS) were fused with K37.3.2 human T cell leukemia cells. The cells produce a SSF that specifically inhibits T cell dependent immune functions. NOTE: this line should be handled with care since one of the fusion partners was derived from a patient with AIDS. Hepatitis B virus precautions are recommended by the depositor. |
| Complete Growth Medium： | Culture medium: RPMI 1640, 90%; fetal bovine serum, 10%. |
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Name of Depositor： | Cornell Res. Fndn., Inc. |
| Deposited As： | human (T cell); human (T cell leukemia) |
| U.S. Patent Number： | |
| References： | Laurence JC. Human T cell hybridomas which produce immunosuppressive factors. US Patent 4,665,032 dated May 12 1987 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
HM2
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | HM2 |
|---|---|
| 商品货号： | TS211990 |
| Organism： | human (T cell); human (T cell leukemia) |
| Cell Type： | hybridoma: helper T lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 Cells Contain RETROVIRUS
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Leukemia,hepatitis |
| Applications： | The cells produce a SSF that specifically inhibits T cell dependent immune functions. NOTE: this line should be handled with care since one of the fusion partners was derived from a patient with AIDS. Hepatitis B virus precautions are recommended by the depositor. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | T cells from a patient with acquired immunodeficiency syndrome (AIDS) were fused with K37.3.2 human T cell leukemia cells. NOTE: this line should be handled with care since one of the fusion partners was derived from a patient with AIDS. |
| Clinical Data： | T cells from a patient with acquired immunodeficiency syndrome (AIDS) were fused with K37.3.2 human T cell leukemia cells. NOTE: this line should be handled with care since one of the fusion partners was derived from a patient with AIDS. |
| Antigen Expression： | Leu 3a; CD4 |
| Genes Expressed： | soluble suppression factor (SSF),Leu 3a; CD4 |
| Cellular Products： | soluble suppression factor (SSF) |
| Comments： | T cells from a patient with acquired immunodeficiency syndrome (AIDS) were fused with K37.3.2 human T cell leukemia cells. The cells produce a SSF that specifically inhibits T cell dependent immune functions. NOTE: this line should be handled with care since one of the fusion partners was derived from a patient with AIDS. Hepatitis B virus precautions are recommended by the depositor. |
| Complete Growth Medium： | Culture medium: RPMI 1640, 90%; fetal bovine serum, 10%. |
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Name of Depositor： | Cornell Res. Fndn., Inc. |
| Deposited As： | human (T cell); human (T cell leukemia) |
| U.S. Patent Number： | |
| References： | Laurence JC. Human T cell hybridomas which produce immunosuppressive factors. US Patent 4,665,032 dated May 12 1987 |
